Primary percutaneous coronary intervention has changed the prognosis of patients with acute coronary syndrome (ACS), leading to a reduction of mortality and mechanical complications. Nearly half of patients with ACS present with multivessel disease, and the risk of major adverse cardiovascular events (MACE) has been shown to be proportional to the extent of coronary artery disease (CAD). [ ]